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Priming of dendritic cells by DNA-containing
extracellular vesicles from activated T cells through
antigen-driven contacts
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Interaction of T cell with antigen-bearing dendritic cells (DC) results in T cell activation, but
whether this interaction has physiological consequences on DC function is largely unex-
plored. Here we show that when antigen-bearing DCs contact T cells, DCs initiate anti-
pathogenic programs. Signals of this interaction are transmitted from the T cell to the DC,
through extracellular vesicles (EV) that contain genomic and mitochondrial DNA, to induce
antiviral responses via the cGAS/STING cytosolic DNA-sensing pathway and expression of
IRF3-dependent interferon regulated genes. Moreover, EV-treated DCs are more resistant to
subsequent viral infections. In summary, our results show that T cells prime DCs through the
transfer of exosomal DNA, supporting a speciﬁc role for antigen-dependent contacts in
conferring protection to DCs against pathogen infection. The reciprocal communication
between innate and adaptive immune cells thus allow efﬁcacious responses to unknown
threats.
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The generation of a speciﬁc immune response against apathogen requires the initial interaction of an antigen-speciﬁc T cell with antigen-presenting cells (APCs), spe-
ciﬁcally dendritic cells (DCs). DCs express antigenic peptides
associated to the major histocompatibility complex (MHC) class
II, and T cell recognition of these complexes leads to the for-
mation of a stable intercellular junction between the cells, the
immune synapse (IS)1. The IS comprises a highly organized
dynamic supramolecular structure that orchestrates the early
events of T cell activation, including the spatiotemporal organi-
zation of the TCR signaling and its costimulatory molecules. The
IS is a cell polarization event involving the redistribution of
membrane-associated receptors and the cytoskeleton, and the
polarization of intracellular trafﬁcking and secretory organelles2.
IS formation generates diverse regulatory checkpoints for the
control of antigen-speciﬁc T cell response by controlling the
spatial and temporal rearrangements of the different T cell
receptors and organelles.
Besides its prominent role in instructing T cell activation, the
IS transmits intracellular signals that direct DC function3. On the
DC side, IS formation rapidly increases the concentration of
MHC class II molecules in the synaptic contact to strengthen
antigen presentation to cognate T cells4. The actin and micro-
tubule cytoskeletons of DCs undergo substantial rearrangements
during IS formation, allowing the polarization of different com-
partments. The relocation of endosomal compartments in DCs
mediates the polarized secretion of cytokines into the synaptic
region5,6, and the trafﬁcking of the major histocompatibility
complexes4. IS formation increases DCs survival by inhibition of
apoptotic signaling, enhancing DC antigen presentation, and T
cell clonal expansion7. The IS integrates the signaling provided by
the APC and the T cell to modulate the function of both cells and
ensure T cell priming, activation, and efﬁcient T cell responses
against cognate antigens. The underlying mechanisms and
functions of the IS in T cells are widely known although the
physiological signiﬁcance of the IS for DCs is still largely
unexplored.
The transfer of bioactive molecules from the T cell to the DC
through the IS constitutes a main vehicle of intercellular com-
munication. T cells and DCs exchange numerous molecules,
including cytokines, membrane receptors, membrane patches,
signaling molecules, or genetic material (mainly functional
microRNAs) during IS formation8. Immune cells readily transfer
membrane fragments to other cells, membrane-associated
receptors, and co-receptors. Several cellular mechanisms med-
iate information transfer between the T cell and the DCs,
including transendocytosis, trogocytosis, formation of tunneling
nanotubes, and polarized secretion of extracellular vesicles
(EVs)8. These exchanges ﬁne-tune the activation of the T cell, e.g.,
by cell-extrinsic depletion of costimulatory proteins from APCs;
capture of MHC class I and II from target cells; downregulation
of TCR peptide-MHC II complexes from APCs; regulation of
DCs gene expression, and transcellular signaling through the
transfer of microRNA-loaded exosomes and TCR-enriched EVs9–
12. Pathogens such as bacteria or virus subvert the architecture of
the IS to enhance dissemination between immune cells13–15. The
IS may act as a portal that supports the transfer of an array of
different molecules or even entire pathogens between T cells and
DCs.
Immune cells secrete a variety of EVs to the extracellular milieu
that can exert diverse immune functions, including antigen pre-
sentation, immune activation, induction of tolerance, or sup-
pression of immune responses16. EVs comprise apoptotic bodies,
ectosomes or microvesicles, and exosomes17,18. Exosomes are
distinguished by their unique endocytic origin. Exosomes form by
invagination of the multivesicular body (MVB) membrane and
are released to the extracellular medium upon the fusion of the
MVB with the plasma membrane. Protein and lipid sorting and
packaging into exosomes occur in a regulated manner involving
mono-ubiquitination and the endosomal sorting complexes
required for transport (ESCRT) machinery, association with lipid
rafts or the tetraspanin network19. Exosomes contain proteins
involved in their biogenesis, vesicle trafﬁcking, lipid membrane
organization, as well as proteins and adhesion receptors speciﬁc
of the producing cell. Exosomes are particularly enriched in
genetic material, mostly RNA species such as small RNAs and
long non-coding RNAs, as well as DNA19. This makes them
attractive candidates to mediate cell-to-cell communication.
However, the ability of the genetic material contained within
exosomes to evoke immune signaling responses in recipient cells
is largely unexplored.
In the present manuscript this question is investigated in the
context of the immune cognate interactions. Data show that T cell
EV contain genomic and mitochondrial DNA (mtDNA) endowed
with the ability to trigger immune signaling in recipient cells. By
using different proteomic, genomic, and cell biology approaches,
it is demonstrated that the unidirectional transfer of DNA within
EVs from T cells to DCs triggers antiviral responses in the DC.
Such DNA-based priming confers DCs resistance to subsequent
viral infections. In conclusion, resulting data illustrate a way by
which T cells promote an alert state in DCs that protects them
against posterior infection driven by the vesicular transfer of
DNA.
Results
T cells shuttle genomic and mitochondrial DNA in exosomes.
EVs transferred from T cell to APC contain many different types
of biologically active molecules, including proteins and genetic
material9,10. To investigate the possible speciﬁc function of the
different components of the biologic material transferred from
the T cell to the DC, the protein and genetic content of EVs
isolated from the culture supernatant of primary T lymphoblasts
were characterized by differential ultracentrifugation20 (Fig. 1a).
Diameters of EVs obtained in the 100,000 × g fraction ranged
from 50 to 200 nm (Fig. 1b), in agreement with the reported size
of exosomes17. Proteomic characterization of T cell EVs identiﬁed
abundant peptides derived from canonical exosome components,
including tetraspanins, endosomal proteins, cytoskeletal proteins,
Rab-related trafﬁcking proteins, heat-shock proteins, and
nucleotide-binding proteins (Supplementary Data 1). Gene
Ontology (GO) term enrichment analysis revealed that a major
fraction of the total number of identiﬁed peptides (>3000 peptides
in four biological replicates) were signiﬁcantly associated with the
nuclear and mitochondrial fractions (Fig. 1c and Supplementary
Data 2). Mitochondrial peptides constituted 7.5 ± 0.3% of the
total exosome proteome, consistent with proteomic studies on
exosomes isolated from other cell types, including immune
cells21,22. EVs isolated from resting T lymphoblasts and cells
activated with a polyclonal stimulus barely contained proteins of
the mitochondrial matrix and the inner or outer mitochondrial
membranes (Fig. 1d). EVs from activated T lymphoblasts con-
tained signiﬁcant amounts of mitochondrial transcription factor
A (TFAM), a highly abundant mtDNA-binding protein, and the
mitochondrial nucleoid-forming protein ATPase family AAA-
Domain containing protein 3 (ATAD3)23 (Fig. 1d). The presence
of the canonical exosomal proteins CD81 and TSG101 in the
puriﬁed 100,000 × g fraction suggested an endosomal origin
(Fig. 1d). TFAM and ATAD3 co-fractionated with the exosomal
proteins CD81 and TSG101 in the 100,000 × g EV fraction from
sucrose-gradient isolation, (Fig. 1e), localizing mtDNA-binding
proteins to exosomes.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05077-9
2 NATURE COMMUNICATIONS |  (2018) 9:2658 | DOI: 10.1038/s41467-018-05077-9 | www.nature.com/naturecommunications
Among EVs, exosomes are enriched in genetic material, mostly
non-coding RNAs24,25. Exosomes from cancer cell lines and
patients contain DNA that reﬂects the mutational status of the
parental tumor cells26,27. Deep-sequencing analysis of DNA in
the EVs secreted by primary T lymphoblasts identiﬁed several
reads that covered nuclear sequences and the entire mitochon-
drial genome (Fig. 2a). These results were conﬁrmed by
polymerase chain reaction (PCR) ampliﬁcation of indicated
regions of the mitochondrial genome and the B2M nuclear gene
from the DNA obtained from the 100,000 × g fraction (Fig. 2b).
The DNA content of the isolated EVs was reduced by DNase
treatment whereas a small fraction of the DNA remained
protected unless vesicles were treated with DNase and a lipid
destabilizing agent (Fig. 2c). Two pools of DNA were present, one
accessible (likely on the surface of the vesicle) and one
inaccessible (likely in the lumen of the vesicle). The presence of
mtDNA in the 100,000 × g EV fraction was conﬁrmed by the
partial co-fractionation on sucrose gradients with the exosomal
proteins CD63 and TSG101 (Fig. 2d). Flow cytometry analysis of
EVs coupled to aldehyde sulfate beads reveals that the majority of
beads were positive for both CD81 and DNA (Fig. 2e, and
Supplementary Fig. 1a). Total internal reﬂection ﬂuorescence
(TIRF) microscopy-based analysis of the co-localization of
exosomal marker CD81 with TSG101 or with DNA in isolated
EVs showed that CD81 fully co-localized with TSG101, but only
partly with DNA (Supplementary Fig. 1b), suggesting the
presence of DNA in a subset of CD81+ exosomes in addition
to other different populations of EVs.
DNA staining in non-permeabilized EVs increased upon
permeabilization (Fig. 2e), conﬁrming that DNA is present both
outside and inside EVs. To examine the oxidative status of EV
DNA, the 8-hydroxydeoxyguanosine (8-OHdG) DNA
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Fig. 1 Exosomes shuttle mitochondrial proteins. a Differential ultracentrifugation protocol for isolating and purifying exosomes from cell culture
supernatants. b Size distribution analysis by Nanoparticle Tracking Analysis (NTA) of puriﬁed EVs from primary human T lymphoblasts. c Gene ontology
(GO) cellular component analysis of peptides identiﬁed in T cell EVs. d Western blot analysis of mitochondrial proteins in EVs obtained from the culture
supernatant of primary human T lymphoblasts with or without treatment with phorbol myristate acetate (PMA) plus ionomycin. Cells and EVs were
blotted for proteins associated with mtDNA (TFAM and ATAD3), for proteins located in the inner mitochondrial membrane (COX1 and Cytochrome C),
the outer mitochondrial membrane (VDAC1), the mitochondrial matrix (mitochondrial manganese superoxide dismutase, MnSOD), and for the exosome
markers TSG101 and CD81. eWestern blot analysis of ATAD3, TFAM, and the exosome markers CD81 and TSG101 in sucrose fractions. EVs obtained from
the culture supernatant of human T lymphoblasts were laid on a discontinuous sucrose gradient and ﬂoated by overnight centrifugation. Gradient fractions
were collected and analyzed by immunoblot to reveal the distribution of mtDNA-binding proteins and exosomal proteins in the sucrose fractions from
lower to higher sucrose density (left to right). Gels shown are representative out of three independent experiments
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modiﬁcation was evaluated as a hallmark of DNA oxidation.
Staining with anti-oxidized DNA antibody (Ab) is also detected
in non-permeabilized EVs (Fig. 2f). In agreement with these
results, chromatin immunoprecipitation of EV lysates with 8-
OHdG Ab followed by DNA isolation and PCR analysis revealed
the presence of several oxidized mtDNA and genomic DNA
regions in EVs when compared with the control isotype Ab
(Supplementary Fig. 1c). To address the preferential localization
of oxidized mtDNA, EVs and mitochondrial fractions of the
corresponding cells were isolated and chromatin immunopreci-
pitation (ChIP) was performed with the 8-OHdG and total DNA
Abs. The enrichment in oxidized mtDNA at the EV fraction was
demonstrated by qPCR analysis of mitochondrial genes in ChIP
and quantiﬁcation of the ratio between oxidized DNA vs total
DNA (Fig. 2f). These results indicate that T cells release EVs
carrying genomic DNA and mtDNA and associated mtDNA-
binding proteins, and that the released DNA is partially oxidized.
Segregation of mtDNA and related proteins into MVB path-
way. The presence of mitochondrial components in EVs
prompted us to investigate the molecular mechanisms controlling
their extracellular release. We ﬁrst co-transfected HEK293 cells
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with TFAM-GFP and a mitochondria-targeted red ﬂuorescent
protein (mitoDsRed), then stained for endosomal markers.
Confocal immunoﬂuorescence analysis excluded co-localization
of mitochondria and TFAM with the early endosome antigen 1
(EEA1), an early endosomal marker. Mitochondria and TFAM
partially co-localized with components of maturing endosomal
structures: HRS (hepatocyte growth factor-regulated tyrosine
kinase substrate), a component of the ESCRT machinery; lyso-
bisphosphatidic acid (LBPA) and ceramide-positive structures,
which are markers of late endosomes and MVBs; and CD63, a
highly abundant tetraspanin found in MVBs and exosomes
(Supplementary Fig. 2a). To rule out potential analysis artifacts
produced by the exogenous overexpression of TFAM-GFP, we
measured the co-localization of endogenous mtDNA-binding
protein single stranded DNA-binding protein 1 (SSBP1) with
EEA1 and CD63 in HEK293 cells treated with low doses of FCCP,
that promotes these events28. Increased co-localization of SSBP1
with CD63 indicates preferential localization in late endosomal
structures (Fig. 3a). The segregation of mitochondrial compo-
nents into maturing endosomal structures was conﬁrmed in
HEK293 cells transfected with constitutively active Rab7 (Q67L),
which enhances endosomal trafﬁcking, resulting in the formation
of enlarged late endolysosomal structures29. Rab7 (Q67L) trig-
gered the accumulation of endogenous TFAM within Rab7-
positive endosomal structures, co-localizing with mitoDsRed
(Fig. 3b). Also, immunogold labeling of TFAM and DNA revealed
their appearance in canonical multivesicular body structures in
electron microscopy studies (Supplementary Fig. 2b), overall
supporting the involvement of the endosomal pathway in the
secretion of mitochondrial components in EVs.
To further elucidate the nature of the vesicles containing
mitochondrial components, we inhibited exosome biogenesis in
T cells by targeting the neutral sphingomyelinase 2 (nSMase2,
SMPD3) (Supplementary Fig. 3a). This enzyme participates in
exosome biogenesis by triggering the budding of intraluminal
vesicles into MVBs30. These conditions reduced the recovery of
exosomal proteins as well as mtDNA-binding proteins and
mtDNA in the puriﬁed 100,000 × g fraction (Fig. 3c), showing
that mtDNA and mtDNA-binding proteins are released through
canonical exosomal pathway and not in other EVs such as
apoptotic bodies. The blocking of exosome biogenesis by silencing
nSMase2 or MVB fusion with the plasma membrane by targeting
Rab27a with speciﬁc shRNAs (Supplementary Fig. 3a) increased
mitochondrial mass, intracellular TFAM levels, intracellular ROS,
and DNA oxidative damage (Fig. 3d). The suppression of
nSMase2 or Rab27a altered mitochondrial morphology and
cristae organization, with increased mitochondrial cristae width
(Fig. 3e). Changes in mitochondrial cristae organization relate to
changes in mitochondrial electron transport chain complex
organization that in turn may result in functional changes in
the respiration ability of cells. Speciﬁcally, tight cristae provide
more efﬁcient mitochondrial OXPHOS31, whereas loose cristae
appear in highly glycolytic cells32. Consistent with a loose
organization of mitochondrial cristae, Rab27a and
nSMase2 silencing signiﬁcantly decreased mitochondrial respira-
tion (Fig. 3f). These ﬁndings indicate that mitochondrial function
is altered in the absence of proper exosome biogenesis and
secretion and suggest that the release of mitochondrial content in
exosomes contributes to mitochondrial homeostasis and mtDNA
metabolism.
We next investigated the contribution of mitochondrial
turnover and degradation mechanisms to the secretion of
mitochondrial components in EVs. Macroautophagy, from here
on referred to as autophagy, is a self-degradation process that
recycles cellular constituents, including misfolded or aggregated
proteins and damaged organelles33. Confocal microscopy analysis
did not reveal co-localization of autophagy proteins ATG5 and
LC3 with MVBs or mitochondria (Supplementary Fig. 3b). Serum
deprivation, a reported autophagy stimulus, decreased exosome
secretion concomitantly with reduced extracellular release of
mitochondrial components (Fig. 3g), consistent with the
autophagy-promoted speciﬁc degradation of MVBs34. Moreover,
inhibition of autophagosome cargo degradation by baﬁlomycin-
A1-mediated blockade of autophagosome–lysosome fusion did
neither alter the detection of TFAM in the exosomal fraction nor
the concentration and size of the puriﬁed EVs (Fig. 3g and
Supplementary Fig. 3c). This ﬁnding indicated that autophago-
some secretion or content release upon baﬁlomycin-A1 treatment
does not account for the presence of mitochondrial components
in EVs. Additionally, speciﬁc siRNA silencing of the late
autophagy mediator LC3 in J77 T cells did not alter exosome
concentration and mitochondrial content (Fig. 3h and Supple-
mentary Fig. 3d). Together, these ﬁndings indicate that the
loading and secretion of mitochondrial material in EVs occurs
independently of general macroautophagy.
DNA and mitochondrial components transfer at immune
contacts. The presence of mitochondrial constituents in exo-
somes led us to hypothesize that mitochondrial material could be
transferred from the T cell to the APC during the formation of
antigen-dependent contacts. To assess this, we ﬁrst evaluated
whether isolated exosomes shuttle mitochondrial components
Fig. 2 T cell exosomes shuttle mtDNA and genomic DNA. a Representation of the number of sequence reads aligned with the mitochondrial genome in EVs
(EVs) and mitochondrial extracts (mtDNA) isolated from human primary T cells. b Upper panel: Diagram of the mitochondrial genome, indicating the
mtDNA regions analyzed by PCR (marked in red: HVRII, tRNALeu, COXII, and 16 S rRNA). Lower panel: Agarose gel showing the ampliﬁcation products of
the different mtDNA regions and the genomic DNA (β2-MICROGLOBULIN) analyzed in EVs puriﬁed from primary human T cells. c Agarose gel
electrophoresis showing the detection of DNA in puriﬁed EVs. EVs obtained from the culture supernatant of J77 T were treated with DNase or DNase and
Tx-100. Levels of mtDNA and genomic DNA were assessed by PCR ampliﬁcation (HVRII and β2-MICROGLOBULIN, respectively). Isolated DNA from J77
T cells treated or not with DNase (DNA+DNase and DNA, respectively) is shown as control for DNase activity. d Distribution of mtDNA and TSG101 and
CD63 in sucrose fractions. EVs from human Jurkat T cells were laid on a discontinuous sucrose gradient and ﬂoated by overnight centrifugation. DNA from
gradient fractions was PCR-ampliﬁed for the HVRII mtDNA region. Proteins from gradient fractions were analyzed by immunoblot for TSG101 and CD63. A
representative gel is shown (n= 3). e Exosomes from primary mouse T lymphoblasts were puriﬁed, coupled to aldehyde sulfate beads, and analyzed by
ﬂow cytometry by staining with the anti-DNA Ab under permeabilizing and non-permeabilizing conditions. Histograms show DNA staining in exosomes.
Numbers are mean ﬂuorescence intensities of the positive population from a representative experiment (n= 3). f Left: Histogram shows oxidized DNA
staining in exosomes coupled to aldehyde sulfate beads with anti-8-hydroxydeoxyguanosine (8-OHdG)Ab under non-permeabilizing conditions. Right:
qPCR analysis showing the enrichment of the indicated mitochondrial genes in the DNA obtained from exosomes and mitochondrial fractions from the
same exosome-producing cells. DNA from both fractions was immunoprecipitated with 8-OHdG and total DNA Abs. Graph shows the ratio between
oxidized DNA and total DNA in exosomes relative to their content in the mitochondrial fractions from the producing cells in duplicates from two
independent experiments. t-test: *P-value < 0.05, ***P-value < 0.0001
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between cells. Puriﬁed exosomes from non-transfected J77 T cells
or cells stably transfected with a mitochondria-targeted ﬂuor-
escent protein, mitoDsRed, were added to Raji B lymphoblastoid
cells, used as APCs. After incubation with exosomes from
J77mitoDsRed cells, recipient cells exhibited mitoDsRed ﬂuores-
cence (Fig. 4a). We next assessed whether exosomes can mediate
intercellular mtDNA transfer. Donor and acceptor cell mtDNAs
were distinguished by the use of conplastic mice with the same
nuclear genome (C57BL/6) but different mtDNA haplotypes,
from the C57BL/6 mice strain (C57C57) or from the NZB strain
(C57NZB)35. These two mtDNA haplotypes differ in 12 missense
polymorphisms identiﬁable by restriction length fragment poly-
morphism (RFLP) analysis (Fig. 4b). Incubation of T cell-derived
exosomes from C57C57 mice with DCs differentiated from the
C57NZB mice resulted in uptake of C57C57 mtDNA by recipient
C57NZB DCs, as shown by the acquisition of the C57C57 haplo-
type and the presence of C57C57 RFLP fragments in exosome-
treated DCs (Fig. 4b), supporting the transfer of mitochondrial
components and mtDNA between cells through exosomes.
The mostly unidirectional nature of exosome transfer from
T cells to DCs9,10 suggested that the exchange of mitochondrial
information between immune cells occurs upon antigen-
dependent contacts. TCR Vβ8+ J77 T cells expressing a
mitochondria-targeted ﬂuorescent protein (mitoYFP) or a
ﬂuorescent version of TFAM (TFAM-DsRed) were co-cultured
with Raji B cells preloaded with Staphylococcus enterotoxin
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superantigen-E (SEE), which mimics antigen recognition when
confronted with TCR Vβ8+ T cells. Flow cytometry analysis
revealed transfer of mitochondria (mitoYFP) and TFAM (TFAM-
DsRED) from T cells to APCs during antigen-dependent
interactions (Fig. 4c). To address this in primary cells, we set
up a model of antigenic presentation in which bone marrow-
derived DC (BMDC) from C57NZB mice presented OVA peptide
to CD4+ T cells from transgenic OT-II mice (C57C57), which are
speciﬁc for that antigen (Fig. 4d)35. After 16 h co-culture in the
presence or absence of OVA peptide, we detected CD4+ T cell
mtDNA only in recipient APCs from co-cultures including OVA
peptide antigen (Fig. 4e), indicating that intercellular mtDNA
transfer requires antigenic triggering. Using CD4+ T cells from
OT-II C57NZB mice and BMDCs from the C57C57 mice, we
conﬁrmed that mtDNA transfer occurred unidirectionally from
T cells to BMDCs (Fig. 4f).
cGAS/STING-IRF3 pathway senses DNA transfer by exosomes.
Mitochondrial components are a major source of danger-
associated molecular patterns (DAMPs). They can trigger
innate immune responses, likely due to their similarities to
bacterial ancestors36. We hypothesized that the transfer of
mitochondrial content and mtDNA during T cell-APC
antigen-dependent contacts may represent a mode of cell-to-cell
transmission of danger-associated messages. To examine this
possibility, we interrogated which signaling pathways were con-
trolled by T cell exosomes in recipient DCs. This was carried out
by characterizing the changes to the gene proﬁle of DCs upon
incubation with T cell exosomes by RNA deep-sequencing
analysis (Fig. 5a). Gene expression proﬁling identiﬁed more
than 1600 signiﬁcantly altered genes in recipient DCs exposed to
T cell exosomes (Supplementary Fig. 4a, b). Exosomes regulated
the expression of a major set of genes involved in interferon (IFN)
type I responses and antiviral activity, including IFN-stimulated
genes (ISGs) Iﬁt1, Iﬁt2, Iﬁt3, Isg15, Usp18, and Cxcl10, and the
antiviral signaling factors Gbp5 and Gbp6 (Fig. 5a). Analysis of
the genes that changed their expression proﬁle in response to T
cell exosomes by Gene Ontology annotation indicated they were
mainly involved in IFN signaling, exogenous DNA and RNA
sensing, bacteria and viruses recognition, and crosstalk between
innate and adaptive immune cells (Fig. 5b). These ﬁndings
suggested that T cell exosomes prime the antiviral innate immune
response in DCs, creating a gene signature that upregulates
antiviral and antimicrobial responses to control pathogen
infection and replication (Fig. 5c). We validated the RNA
sequencing results by PCR for the genes Cxcl10, Isg15, Iﬁt1, Iﬁt3,
Usp18, and Stat1 (Fig. 5d). One of the most relevant pathways
involved in ISG expression depends on cGAS/STING interaction
upon cytoplasmic detection of endogenous or exogenous DNA37.
cGAS functions as a main sensor of viral and bacterial DNA in
the cytoplasm of infected cells. Upon its activation by DNA
detection, it generates the second messenger cyclic dinucleotide
cGAMP, which binds to and activates STING. STING in turn
activates TANK-binding Kinase 1 (TBK1), which phosphorylates
interferon regulatory factor 3 (IRF3) to promote its translocation
to the nucleus, where it induces the expression of IFNβ and ISGs.
Triggering of cytoplasmic DNA sensors is associated with intra-
cellular clustering of STING38. Consistent with activation of the
cGAS/STING DNA-sensing pathway, exosomes induced a sig-
niﬁcant aggregation of STING in DCs (Fig. 5e). The expression of
ISGs in response to exosomes was reduced in STING-deﬁcient
(StingGt/Gt) DCs (Fig. 5d), and completely abrogated in Irf3−/−
DCs (Fig. 5f). The role of exosomal DNA in triggering these
responses was evaluated by treating exosomes with DNase. DNase
treatment signiﬁcantly reduced the ability of exosomes to trigger
the activation of interferon-related genes in recipient WT DCs
(Fig. 5g), suggesting that the DNA located in the outer surface of
exosomes is important for full induction of antiviral responses in
recipient cells. To ascertain whether DNA located into the lumen
of exosomes may also contribute to antiviral responses in reci-
pient DCs, we genetically engineered a plasmid expressing DNase
II fused to the intraluminal domain of the exosome-enriched
protein CD63. qPCR analysis of isolated exosomes showed that
exosomes from cells stably expressing CD63-DNase II contain
less mitochondrial DNA than exosomes from control cells stably
expressing wild-type CD63 (Supplementary Fig. 4c). Exosomes
from cells expressing CD63-DNase II triggered a lower antiviral
response in recipient cells compared with exosomes obtained
from CD63-expressing control cells (Supplementary Fig. 4d).
Overall, these results support that DNA on the surface and the
inside of T cell exosomes can act transcellularly, i.e., in recipient
DCs, to prime antiviral responses through activation of the
STING-IRF3 DNA-sensing pathway.
Primed antiviral responses in DCs by synaptic T-exosomes. We
next assessed whether antigen-driven T-APC contacts trigger
antiviral responses in recipient cells through the transfer of
exosomal components. Gene expression analysis revealed that
Fig. 3 Mitochondrial components segregate into MVBs and are secreted in exosomes. a Confocal co-localization analysis in HEK293 cells treated with
FCCP (4 h) and stained with SSBP1 (red), EEA1 and CD63 (green). Bar, 10 µm. Graph shows means for Mander’s co-localization coefﬁcient for SSBP1 and
EEA1 or CD63 (n= 3). t-test: ***P-value < 0.0001. b Confocal co-localization analysis in HEK293 cells co-transfected with Rab7-Q67L-GFP (Rab7mutGFP,
green) and mitoDsRed (red), and immunostained for TFAM (purple) and nuclei (HOECHST 58, blue). Center and right images show high magniﬁcation of
left images (Rab7-Q67L-GFP and mitoDsRed in upper panels; Rab7-Q67L-GFP and TFAM in lower panels). Charts: Fluorescence proﬁles along the
corresponding white lines. Bar, 10 µm. cMitochondrial components in the exosome fraction obtained from equal numbers of shControl and shnSMase2 J77
T cells. ATAD3, TFAM, and CD63 were detected by immunoblot; mtDNA was detected by PCR for HVRII. Graph: Quantiﬁcation of exosomal proteins and
mtDNA in a representative experiment (n= 3). d Flow cytometry analysis of mitochondrial mass (Mitotracker green), intracellular ROS levels (DCFDA
staining), oxidized DNA (8-OHdG Ab staining), and endogenous TFAM in HEK293 cells knocked down for nSMase2 and Rab27a. Graphs: Quantiﬁcation
from 5–8 independent experiments (Mean). t-test *P-value < 0.05; **P-value < 0.001. e Electron microscopy images show defects in mitochondrial
ultrastructure and cristae organization in shnSMase2 and shRab27a HEK293 cells. Graph: Quantiﬁcation of mitochondrial cristae width (Mean). t-test:
***P-value < 0.0001. f Graph: Basal oxygen consumption rate (OCR) of control, shnSMase2 and shRab27a HEK293 cells. Dots represent mean from three
independent experiments run in duplicate or triplicate. t-test, *P-value < 0.05, ***P-value < 0.0001. Chart: OCR from shControl, shnSMase2 and shRab27a
HEK293 cells in response to oligomycin (Oligo), fccp, and rotenone plus antimycin A (Rot/AA). (n= 2; mean ± S.E.M.). g Western blot analysis of
exosomes from Jurkat T cells left untreated, serum-starved overnight or treated with baﬁlomycin A. Membranes were blotted for TFAM, CD81, and CD63.
Graph: Nanoparticle concentration in the exosomal fractions (mean, two independent experiments). h Western blot analysis of exosomes obtained from
Jurkat T cells transfected with control or LC3 siRNA. Graph: Nanoparticle concentrations in the exosomal fractions (mean, n= 2). Western blots are
representative out of three independent experiments
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Fig. 4 Transfer of mitochondrial components during immune cognate interactions. a Flow cytometry analysis of Raji B cells incubated overnight with exosomes
from J77 T cells control or stably expressing mitoDsRed (Representative experiment, n= 3). b Up: RFLP analysis of the mitochondrial genomes of C57C57 and
C57NZB mice. Total DNA is from C57C57 T lymphocytes and C57NZB BMDCs. C57C57 haplotype includes a BamHI restriction site; enzyme digestion results in two
smaller fragments of 414 pb and 250 pb. Digestion of PCR products from C57 NZB haplotype results in a single band of 664 pb (full length). Down, RFLP detection
of exogenous mtDNA in C57NZB DCs incubated overnight with increasing amounts of exosomes from C57C57 CD4+ T lymphoblasts. 414 pb and 250 pb fragments
appear in C57NZB DCs upon addition of exosomes (lanes 1/3, 2/3, and 3/3). Chart: Intensity proﬁle of the RFLP analysis; arrows indicate the C57 mtDNA
haplotype. C57C57CD4+ lane displays a band of 664 pb which corresponds to an uncompleted digestion of the PCR product in the RFLP analysis and a high
exposure of the image. Representative experiment (n= 3). c Exosome and mitochondrial transfer to unpulsed or SEE-pulsed Raji B cells (CMAC) from J77 T cells
expressing the exosomal protein CD63GFP, the mitochondria-targeted mitoYFP or the mtDNA-binding protein TFAM-DsRED. Dot plots, Cell populations after co-
culture. Red boxes enclose Raji B cells that have acquired exosomal or mitochondrial ﬂuorescent markers (percentage from total Raji cells). Graphs: Percentage of
Raji B cells acquiring ﬂuorescence upon IS formation from 3 to 5 independent experiments; mean, t-test *P-value < 0.05, **P-value < 0.001, ***P-value < 0.0001. d
Workﬂow for mtDNA transfer detection by RFLP during immune cognate interactions. e Detection of exogenous C57C57 mtDNA from donor OT-II CD4+ T cells in
recipient C57NZB DCs upon antigen stimulation (OVA). Gels, RFLP analysis of the mitochondrial genomes (n= 2). Chart: Intensity proﬁle for RFLP. f RFLP analysis
of the mitochondrial genomes of C57C57 and C57NZB mice. Left gel shows RFLP analysis from C57C57 T lymphocytes and C57NZB DCs. Right gel: lack of exogenous
C57C57 mtDNA from donor DCs in recipient C57NZB CD4+ T cells. Chart: intensity proﬁle for RFLP analysis. Representative experiment (n= 3)
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Fig. 5 Exosomes prime antiviral innate immune responses in DCs. a Upper panel: Workﬂow for RNAseq analysis of DCs upon T cell exosome acquisition.
Lower panel: RNAseq heat maps of four DC biological replicates with or without exosome uptake (DCs+ EXO vs DCs). The panel shows upregulated
(yellow) or downregulated (blue) genes with the highest signiﬁcant fold changes. b GO annotation of the biological processes differently regulated upon
exosome addition; p-values are presented for the top-ranking biological processes. c Ingenuity analysis predictions of DC pathways upregulated or
downregulated upon acquisition of T cell exosomes. d Quantitative real-time PCR (qRT-PCR) of antiviral response genes in wild-type DCs and StingGt/Gt
DCs upon exosome addition. Mean, n= 4, t-test ***P-value < 0.0001 and ****P-value < 0.00001. e Upper panel: Immunoﬂuorescence microscopy images
showing STING aggregation (green) in DCs upon exosome addition. For clarity, DCs were stained for actin with phalloidin (purple) and for nuclei with
HOECHST 58 (blue). Bar, 10 µm. Lower panel: Quantiﬁcation of STING aggregate size and number upon exosome addition. Mean, n= 26 (control), 35
(STING), t-test ***P-value < 0.0001 and ****P-value < 0.00001. f qRT-PCR analysis of antiviral response genes in wild-type DCs and Irf3−/− DCs upon
exosome addition. Data (d, f) show quantiﬁcation of mRNA levels of a representative experiment with four mice per genotype: t-test *P-value < 0.05, **P-
value < 0.001, ***P-value < 0.0001, and ****P-value < 0.00001. g qRT-PCR analysis of antiviral response genes in wild-type DCs upon addition of exosomes
left untreated or pre-treated with DNase. Data shows mean from three independent experiments. t-test *P-value < 0.05
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DCs upregulated ISGs upon immune cognate interactions with
OT-II CD4+T cells (Fig. 6a). Control or SEE-pulsed Raji B cells
were co-cultured with CD63GFP-expressing J77 T cells and then
sorted according to the level of GFP-labeled exosome uptake
(Fig. 6b). Raji B cells with higher acquisition of T cell exosomes
showed more potent antiviral responses, as measured by their
increased expression of Cxcl10 (Fig. 6b), supporting that exosome
transfer during antigen-driven immune contacts primes antiviral
responses in DCs.
To assess the effect of exosome-boosted antiviral responses in
recipient cells, we incubated DCs with T cell exosomes, infected
them with GFP-expressing recombinant vaccinia virus, and
monitored virus spreading and infection. Pre-incubation of DCs
with T cell exosomes reduced viral infection, as measured by the
number of vaccinia-GFP-positive DCs (Fig. 6c). Antigen-
dependent interactions between DCs and CD4+ T cells increased
protection against further vaccinia virus infection of the DCs
(Fig. 6d and Supplementary Fig. 5a). This effect was dependent
on T cell exosomes, since inhibition of their biogenesis by pre-
treatment of T cells with increasing concentrations of manumycin
A, reduced DCs protection against subsequent viral infection
(Fig. 6e), without interfering signiﬁcantly with T cell viability and
activation (Supplementary Fig. 5b, c). Collectively, these results
indicate that T cell exosomes delivered during antigen-dependent
contacts boost inﬂammatory responses of DCs, protecting them
against subsequent viral infection.
Discussion
The establishment of immune cognate interactions between
T cells and APC is a key element of T cell activation, i.e., the
conversion of naive T cells into effector cells, leading to the
efﬁcient clearance of pathogens through the adaptive arm of the
immune response. This study demonstrates that this signal dis-
plays retrograde feedback, in which the T cell imposes additional
changes to the activity of the APC, priming it to respond better in
the case of subsequent infections by the same pathogen, or a
similar one. We have also identiﬁed EVs as the vessels of the
information that triggers these changes in DCs (the type of APC
studied throughout), promoting an antiviral response with
induction of IFN-related stimulated genes. A key observation is
that these effects require antigenic stimulation. This is crucial
because it ensures that the acquisition of inﬂammatory (or anti-
viral) traits is limited to situations in which a speciﬁc stimulus,
i.e., the pathogen, is triggering these responses. It also has the
potential to drastically alter the fate of the DC. DCs supposedly
die in lymph nodes after cognate interactions. This is based on
evidence of the onset of autoimmune disease when DC apoptosis
is inhibited39. We postulate that, even if DC are eliminated after
activating naive T cells in an antigen-speciﬁc-dependent manner,
T cell exosomes could salvage the DC by reverting the onset of the
apoptotic program. This is consistent with the observation
that DCs receive pro-survival signals after IS formation, reducing
the percentages of apoptosis in vitro and in vivo7. Hence,
the reported disappearance of DCs from the lymph nodes after
the IS40 could be explained due to their programmed cell death
but also due to their migration to other tissues, particularly if they
have been ﬁne-tuned by T cell exosomes. In fact, DCs can live for
15 days in the lymph node after an immune challenge, and are
able to present antigens ex vivo to CD4+ T cells41. There is scant
evidence of this type of priming, but some indirect evidence
points to the potential importance of this mechanism. For
example, tissue-resident memory T cells (TRM) have been shown
to allow superior protection to homologous infection compared
to circulating memory T cells. These TRM can become instructors
of innate immune system by initiating a local antiviral state after
reinfection that depends on the secretion of pro-inﬂammatory
cytokines such as TNF, IL-2, or IFN-γ that rapidly initiate an
innate immune response in the infected tissues42–44. These
experimental observations suggest the existence of cross-priming
elements that are transferred by the exposure to one pathogen to
improve the response against other pathogens. Hence, it is
tempting to speculate a role for exosomes and DNA transfer in
this enhanced antiviral protection exerted by tissue-resident
memory T cells.
The mechanism proposed here would function as a mechanism
of innate memory, adapting the DC response during antigenic
challenge. Obviously, DCs do not bear genetic mechanisms to
modulate their ability to recognize antigens similar to the
recombination observed in B cells and T cells. However,
increasing evidence has demonstrated that DCs and macrophages
bear long-lasting modiﬁcations to their epigenetic status after
infection or vaccination, leading to enhanced responsiveness
upon secondary stimulation by microbial pathogens, increased
production of inﬂammatory mediators, and enhanced capacity to
eliminate infection45. We propose that T cell EVs are powerful
DC reprogramming tools that enhance the adaptation of the
innate cell against the pathogen. Although this is obviously a
short-ranged mechanism, the delivery of T cell EVs to circulating
ﬂuids and their subsequent capture by distant APC could play a
signiﬁcant role in boosting vaccination and the induction of long-
distance preparation against infection.
A most striking result is the speciﬁcity of the type of cellular
response evoked by the DNA packaged into EVs: type I IFN
response and expression of ISGs. Although nuclear DNA is the
main endogenous ligand for cGAS, growing evidence indicates
a role for mtDNA as a ligand for cGAS in certain conditions.
Mitochondrial DNA as well as other mitochondrial constituents
such as N-formyl peptides (NFPs), mitochondrial lipids such as
cardiolipin, or nuclear-encoded mitochondrial proteins, can
elicit a local or systemic innate immune response in conditions
of massive episodes of cell damage36. Intriguingly, mtDNA can
also be released in a rapid, “catapult-like” manner by neu-
trophils to create “extracellular traps” that exert antibacterial
activity and activate the release of pro-inﬂammatory cyto-
kines46,47. In this regard, secretion of interferogenic mtDNA by
neutrophils in systemic lupus erythematosus (SLE) patients
contributes to disease by activating the production of potent
IFN type I responses48,49. Intracellularly, the accumulation of
mtDNA molecules in the cytosol upon mtDNA stress has been
also shown to activate type I IFNs response through the cGAS/
STING pathway50, contributing to the acquisition of an anti-
viral state. Our results demonstrate that in DCs, the DNA
present in EVs activate type I IFN responses and expression of
ISGs. The contribution of cytoplasmic sensors, e.g., STING,
appears to be only partial, and other DNA receptors localized at
the endosome or the plasma membrane could also detect the
DNA present on the surface or the lumen of EVs and activate
interferon response factors, thus contributing to the induction
of a potent antiviral response. Then, understanding which
sensors or receptors detect the DNA transported in EVs; and
whether the mechanisms (endocytosis, phagocytosis, back-
fusion of endosomes) by which vesicular content is acquired by
recipient cells affect DNA responses are questions that deserve
further investigation. In this study we found that the DNA-
sensing responses were abrogated in an IRF3-dependent man-
ner. Also, elimination of exosomal DNA, either by DNase
treatment or overexpression of DNase II fused to the intra-
luminal domain of the exosome-enriched protein CD63, sig-
niﬁcantly reduced the expression of antiviral-related genes.
However, we cannot rule out the contribution of other EVs
constituents in triggering innate immune signaling in DCs.
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Fig. 6 Antigen-driven immune interactions prime DCs to pathogen infection. a qRT-PCR analysis of the DC antiviral response upon antigen-dependent
contacts. Gene expression was analyzed in sorted DCs after 16 h conjugate formation. Data shows mean from ﬁve independent experiments. t-test *P-value <
0.05. b Left: Flow cytometry analysis of exosome uptake after co-culture of J77 T cells stably expressing CD63GFP with unprimed or SEE-primed Raji B cells.
After immune interactions, Raji B cells (CMAC) were sorted according to the level of exosome uptake (CD63GFP content). Dot plots show the GFP signal in
pre-sort and post-sort Raji populations. Right: Chart shows qRT-PCR analysis of Cxcl10 in low and high exosome uptake SEE-primed Raji B cell populations.
Mean; n= 3. t-test *P-value < 0.05. c Upper panel: Time ﬂow for the analysis of exosome-mediated antiviral protection. DCs were incubated for 4 h with T cell
exosomes, infected with vaccinia-GFP, and analyzed for the level of infection by ﬂow cytometry. Lower left: Dot plots of DCs infected with vaccinia-GFP with or
without exosome pre-treatment. Lower right: Percentage of infected DCs at different viral loads with or without exosome pre-treatment. Mean; n= 4; t-test
*P-value < 0.05, **P-value < 0.01. d Upper panel: Time ﬂow for the analysis of exosome-mediated antiviral protection after immune cognate interactions.
Unloaded or OVA peptide-loaded DCs were incubated for 4 h with CD4+OT-II T cells, infected with vaccinia-GFP, and analyzed for the level of infection by
ﬂow cytometry. Lower left: Dot plots of DCs (gated on CD11c) infected with vaccinia-GFP in the presence or absence of OVA peptide. Lower right: Percentage
of infected DCs at different viral loads in the presence or absence of antigen-dependent immune contacts. Mean; n= 3–6; t-test *P-value < 0.05, **P-value <
0.01, ***P-value < 0.0001. e Unloaded or OVA peptide-loaded DCs were incubated for 4 h with CD4+OT-II T cells pre-treated with increasing amounts of
manumycin, infected with vaccinia-GFP, and analyzed for the level of infection by ﬂow cytometry. Graph shows the ratio of infected DCs. Data (b, c, d, e) are
Mean from quantiﬁcation of ﬁve to seven independent experiments: t-test *P-value < 0.05, **P-value < 0.001, and ***P-value < 0.0001
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The molecular mechanism of inhibition of exosome produc-
tion by manumycin A in T cells was initially related to neutral
sphingomyelinase inhibition and lack of ceramide production, as
reported previously9. Our data show that manumycin A prevents
exosome production in T cells without interfering with activation
at 1.0 and 2.5 µM. In addition, manumycin effect on exosome
biogenesis has been recently reported to be dependent on its
inhibition of Ras farnesyl transferase51. Therefore, the effect of
manumycin on T cells maybe mediated by a combination of
effects on these systems, leading to a ﬁnal defect on exosome
production. Manumycin has also been described to induce a
certain degree of cell death mainly in tumor cells through Ras
Farnesyl transferase and IKKbeta inhibition activity51,52.
Although our data show a decrease of 13% in T cell viability at
manumycin 2.5 µM, since the ratio of T cells: DCs in the acti-
vation assay is 5:1, the viable, active T cells present would con-
stitute a 4.35:1 effective ratio, enough to promote the antiviral
response in DCs. Such a modest degree of cell death would not
explain the complete loss of antiviral protection by manumycin.
Our observations of mtDNA and mtDNA-binding proteins
loading into EVs in an autophagy-independent manner indicate
the existence of an additional targeting mechanism. The role of
mitochondrial component release as a danger indicator to sur-
rounding cells is well documented36, but our data suggest that the
MVB endosomal route can target these components actively into
exosomes. Although the signals that mediate the loading and
incorporation of mitochondrial components into late endosomes/
MVBs remain unidentiﬁed, an attractive possibility is that small
organelle fragments containing mitochondrial nucleoids might
bud toward the cytosol depending on their oxidative status, and
are subsequently loaded and incorporated into the endolysosomal
compartment for their degradation or secretion. Cytosolic accu-
mulation of mtDNA has been described following mitochondrial
dysfunction and inﬂammatory stimulation36,53, and a similar
process may operate in the release of mtDNA to the cytoplasm
and its subsequent incorporation into ILVs during MVB
maturation. Alternatively, mitochondria-derived vesicles (MDVs)
transport mitochondrial components into lysosomes, peroxi-
somes, and MVBs54, and they might participate in the loading of
mitochondrial components into exosomes. Our results demon-
strating the presence of oxidized DNA in exosomes suggest that
these EVs may cooperate to manage cellular damage by releasing
mitochondrial proteins and oxidized DNA, acting as a “escape
valve” to partially expel mitochondrial damage outside the cell.
Recently, a role for exosomes in the secretion of harmful genomic
DNA has been documented55. Supporting this role of exosomes
in the preservation of cellular homeostasis, we found that inhi-
bition of exosome biogenesis and secretion impairs mitochondrial
structure and function. A recent study identiﬁed a role for the
secretion of large vesicles containing protein aggregates and
organelles in Caenorhabditis elegans in maintaining mitochon-
drial homeostasis56. Whereas exosomes facilitate the secretion of
harmful or damaged mitochondrial components and sustain
mitochondrial function is a possibility that warrants further
investigation.
Transfer of entire mitochondria between cells or acquisition of
mitochondria from the environment in a functional and trans-
missible way has been demonstrated in culture cells57–59, and
in vivo in a cancer context60–62. Recent reports suggested that the
intercellular transmission in vivo of mitochondria and/or mito-
chondrial components exerts a beneﬁcial effect on the recipient
damaged cells63–66.The beneﬁts in all cases are attributed to the
assumption that entire healthy functional mitochondria travel
and colonize the recipient cells; however, the use of interspecies
mix for donor cells in some cases and the lack of evidence of
long-lasting colonization of the recipient cells by the foreign
mtDNA question this interpretation. The role of the intercellular
transmission of deﬁned mitochondrial components and speciﬁ-
cally mtDNA as part of a complex intercellular signaling
mechanism, raises the possibility that the observed beneﬁcial
effects of transmission of mitochondrial components would be
consequences of activation of survival pathways rather than the
transmission of fully functional organelles able to colonize the
recipient cells. This could, for instance, explain the positive effects
of interspecies (human/mice) experiments, since it is well
described the interspecies incompatibility between nuclear and
mtDNA.
In summary, this study provides a physiological mechanism for
the transfer of mitochondrial components and genome transfer in
the context of immune cognate interactions, laying the founda-
tion of a model in which the transfer of DNA between immune
cells constitutes a signal-dependent mechanism for alerting
responses in innate immune cells.
Methods
Antibodies and reagents. The following antibodies were used for Western blot-
ting: mouse anti-human CD63 (Calbiochem, OP171; 1:1000); mouse 5A6 anti-
human CD81 (Santa Cruz, sc-23962; 1:500); mouse anti-human TSG101 (Abcam,
ab83; 1:1000); mouse anti-GFP (Clontech, 632381; 1:2000); anti-TFAM (Abcam,
ab47517; 1:500), anti-HRS (Abcam, ab72053; 1:500), anti-COX1 (Human Complex
IV subunit I, Invitrogen, 459600; 1:1000), anti-VDAC1 (Abcam, ab14734; 1:1000),
and anti-Cyt C (Abcam, ab110325; 1:1000), anti-LC3 (Cell Signaling, 2775 s;
1:1000); anti-MnSOD (Enzo Life Sciences, ADI-SOD-110; 1:1000), anti-ATAD3
(Abnova, H00055210-D01), anti-Tubulin (Sigma, T6199: 1:2000), anti-nSMase2
(RD System, MAB7184;1:1000) and anti-Rab27a (RD System, AF7245; 1:1000).
Peroxidase secondary antibodies were from Thermo Scientiﬁc: Goat anti-mouse
peroxidase (31430; 1:5000) and goat anti-rabbit peroxidase (31460; 1:5000).
For immunoﬂuorescence and ﬂow cytometry the following antibodies were
used: anti-CD63 (clone Tea 3/18, generated in the laboratory; 1 µg/ml), anti-HRS
(Abcam, ab72053; 1:200), anti-EE1A (Santa Cruz, sc-137130; 1:200), anti-LBPA
(Tebu-Bio; ML062915-21), anti-ceramide (Sigma, C8104-50TST: 1:200), anti-8
hydroxyguanosine (Abcam, ab62623; 1:500), anti-DNA AC-30-10 (Progen, 61014;
1:50), anti-Tmem173/Sting antibody (Proteintech, 19851-1-AP; 1:100) and anti-
SSBP1 (Novus Bio, NBP1-80720: 1:200), and anti-CD69 (BD Pharmigen, 552879;
1:200)
Human cells. Human T lymphoblasts were isolated from buffy coats obtained
from healthy donors by separation on a Biocoll gradient (Biochrom). After 30 min
of adhesion at 37 °C, non-adherent cells were cultured in RPMI (Gibco) for 2 days
in the presence of 5 μg/ml phytohemagglutinin (PHA) to induce lymphocyte
proliferation. T lymphoblasts were maintained by addition of IL-2 (50 U/ml) to the
medium every 2 days over 8–10 days. For T lymphoblast restimulation, cells were
incubated overnight with 50 ng/ml PMA and 750 ng/ml ionomycin.
Human peripheral blood mononuclear cells (PBMC) were isolated from buffy
coats obtained from healthy donors by separation on a Lymphoprep gradient
(Nycomed, Oslo, Norway) according to standard procedures. Buffy coats of healthy
donors were received from the Blood Transfusion Center of Comunidad de
Madrid, and all donors signed their consent for the use of samples for research
purposes. All the procedures using primary human cells were approved by the
Ethics Committee of the Hospital Universitario de la Princesa. Monocytes were
puriﬁed from PBMC by a 30 min adherence step at 37 °C in RPMI supplemented
with 10% fetal calf serum. Non-adherent cells were washed off and the adhered
monocytes were cultured in RPMI, 10% FCS containing IL-4 (10 ng/ml, R&D
Systems Inc, Minneapolis, MN USA) and GM-CSF (200 ng/ml, Schering-Plough,
Madrid, Spain). Cells were cultured for 6 days, with cytokine re-addition every
other day, to obtain a population of immature hDC.
The human Jurkat-derived T cell line J77 E61 (TCR Vαl. 2 Vβ8) (from NIH
AIDS reagent program) and the lymphoblastoid B cell line Raji (Burkitt
lymphoma) (from ATCC, CCL-86™) were cultured in RPMI (Gibco) containing
10% FBS. Stable cell line clones overexpressing CD63-GFP were generated by
transfection and selection with G418 (1 mg/ml, Sigma).
HEK293T cells (from ATCC, CRL-3216™), were cultured in DMEM (Gibco)
containing 10% FBS. For co-localization experiments HEK293T cells were treated
with 1 µM FCCP 4 h (low dose), then washed and immediately ﬁxed with PFA 6%.
HEK923T cells were used as a bona-ﬁde cell factory for exogenous protein
synthesis and organelle compartmentalization.
Cells were regularly tested for mycoplasma contamination by PCR.
Mice and cell differentiation and activation. Mice were housed under speciﬁc
pathogen-free conditions at the Centro Nacional de Investigaciones Cardiovascu-
lares Carlos III (CNIC), and experiments were approved by the CNIC Ethical
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Committee for Animal Welfare and by the Spanish Ministry of Agriculture, Food,
and the Environment. Animal care and animal procedures license were reviewed
and approved by the local Ethics Committee for Basic research at the CNIC Ethical
Committee for Animal Welfare and the Organo Encargado del Bienestar Animal
(OEBA) del Gabinete Veterinario de la Universidad Autonoma de Madrid (UAM).
C57BL/6 JOlaHsd (or C57BL/6), C57BL/6 OT-II, C57BL/6JOlaHsd with NZB
mtDNA (or C57BL/6NZB) and C57BL/6NZB OT-II mice were bred under speciﬁc
pathogen-free conditions at the CNIC (Madrid, Spain) in accordance with Eur-
opean Union recommendations. The C57BL/6JOlaHsd strain does not harbor the
nicotinamide nucleotide transhydrogenase (NNT) spontaneous mutation that
renders the encoded enzyme undetectable, and which is characteristic of the
C57BL/6J strain provided directly by Jackson Laboratories. C57BL/6NZB OT-II
mice were obtained by backcrossing C57BL/6 OT-II transgenic males with C57BL/
6NZB females. StingGt/Gt (STING-deﬁcient) mice were provided by Dr. Gloria
González-Aseguinolaza, Gene Therapy and Regulation of Gene Expression Pro-
gram, Center for Applied Medical Research, Health Research Institute of Navarra
(IdisNA), Pamplona, Spain. These mice have a single nucleotide variant (T596A)
which is a null mutation resulting in failure to produce STING protein67. Irf3−/−
mice were kindly provided by Prof. Adolfo García Sastre, Icahn School of Medicine
at Mount Sinai, New York, USA.
CD4+ T cells were obtained from spleen-cell suspensions obtained from
C57BL/6 OT-II transgenic mice. Splenic cells were incubated for 30 min at 4 °C
with a biotinylated anti-CD4 antibody (BD Pharmingen) followed by extensive
washing with PBS, 1% BSA, 5 mM EDTA. Cell suspensions were then incubated for
20 min at 4 °C with streptavidin microbeads (MACS; Miltenyi Biotec) and washed
with PBS, 1% BSA, 5 mM EDTA. CD4+ T cells were obtained by positive selection
using the auto-MACS Pro Separator (Miltenyi Biotec).
Bone marrow-derived dendritic cells (BMDCs) were obtained either from
C57BL/6, C57BL/6NZB, StingGt/Gt, or Irf3−/− mice by incubating primary bone
marrow cells for 9–10 days in RPMI (Gibco) supplemented with 1% sodium
pyruvate, 50 U/ml penicillin, 50 µg/ml streptomycin, 5 × 10−5 M 2-
mercaptoethanol, and 10% FBS (all from Invitrogen) supplemented with 20 ng/ml
recombinant GM-CSF (ImmunoTools).
For T cell blasting, naive CD4+ T cells were isolated from spleen and lymph
nodes and cultured for 48 h with 2 µg/ml concanavalin A (Sigma). Cells were then
incubated with 50 U/ml human recombinant IL-2 (Glaxo) every 2 days for at least
7 days to obtain differentiated T lymphoblasts. For antigen-speciﬁc restimulation,
T lymphoblasts were conjugated with BMDCs and stimulated overnight in vitro
with 100 ng/ml lipopolysaccharide (LPS) in the presence or absence of 10 μg/ml
ovalbumin (OVA) peptide.
Cell transfection and plasmids and interference RNA. J77 cells were transfected
with the corresponding plasmids by electroporation; 20 × 106 cells were resus-
pended in Opti-MEM (Gibco; 5 × 107 cells per ml) with 20 μg of plasmid DNA and
electroporated with a Gene Pulser Xcell electroporator (Bio-Rad) at 1200 μFa, 240
mV, 30 ms in 4 mm Bio-Rad cuvettes (Bio-Rad). Fluorescence-positive cells were
FACS sorted, cloned, and cultured in RPMI containing 2 mg/ml G418 (Invitrogen).
HEK293T cells were transfected using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions.
The following plasmids were used: mitoDsRed and mitoYFP, (kindly provided
by Prof. L. Scorrano, Venetian Institute for Molecular Medicine, Italy), TFAM-GFP
and TFAM-DsRED (generated by inserting the human TFAM cDNA into the
pEGFP and DsRED plasmids), EGFP-Rab7A Q67L, LC3-GFP and ATG5-GFP
(obtained from Addgene: plasmids 28049, 24920 and 22952, respectively), shRNA
pLKO control plasmid, shnSMase2 and shRab27a shRNAs (obtained from Open
Biosystems), and CD63-GFP9.
Construct of DNase II with CD63 intraluminal domain: Following Gibson
Assembly Protocol (New England Biolabs) hDNaseII (Human DNase II Gene ORF
cDNA clone in cloning vector, HG16372-G, Sino Biological Inc) was inserted in
CD63-GFP plasmid in the intraluminal domain. CD63-GFP plasmid was cut with
EcoRI. The following primers were used to amplify insert: Fw_DNaseII-EcoRI:
CGAGCTCAAGCTTCGATGATCCCGCTGCTGCT Rv_DNaseII-EcoRI:
TACCGTCGACTGCAGGGATCTTATAAGCTCTGCTGG GC
T cell lines and human T lymphoblasts were transfected with a speciﬁc double-
stranded siRNA targeting human LC3 (GGUGCCUGUAGGUGAUCAA) or
negative control siRNA (Eurogentec), using the Gene Pulser II electroporation
system (Bio-Rad Laboratories) or the Nucleofector system (Amaxa Biosystems).
When indicated, at 24 h post transfection, cells were cultured in exosome-depleted
medium for 20 h and exosomes were isolated from supernatants.
Lentiviral infection. J77 cells with downregulated nSMase2 and Rab27a expression
were generated by infection with lentiviral vectors expressing speciﬁc shRNAs.
HEK293T cells were co-transfected using the Lipofectamine 2000 system (Invi-
trogen) with pCMV-ΔR8.91-(Delta 8.9), pMD2.G-VSV-G, and plasmids encoding
shRNAs targeting nSMase2, Rab27a, or the corresponding shRNA pLKO control
plasmids (Open Biosystems). Supernatants were collected after 48–72 h, ﬁltered
(0.45 μm), and added to J77 or HEK293 cell cultures. Cells were centrifuged
(2000 × g, 2 h) and incubated for 4 h at 37 °C. Medium was replaced with RPMI
containing puromycin (4 μg/ml).
Conjugate formation and assessment of mtDNA transfer. To assess mtDNA
transfer during immune cognate interactions, differentiated C57BL/6NZB receptor
BMDCs were loaded with calcein (37 °C, 20 min), extensively washed, and then co-
cultured in the presence of ovalbumin (OVA) peptide (10 μg/ml) with C57BL/6
CD4+ OT-II T cells (5:1 T cell/DC ratio; 16 h). To assess mtDNA transfer from
BMDCs to CD4+ OT-II cells, C57BL/6 BMDCs and C57BL/6NZB OT-II CD4+
T cells were conjugated (1:5 T cell/DC ratio; 16 h). Conjugates were blocked with
Fc-block (CD16/CD32, BD Pharmingen), washed in PBS, 1% BSA, and incubated
with antibodies against MHCII and CD3 (BD Pharmingen) diluted in PBS, 1%
BSA. Viable cells were identiﬁed by propidium iodide exclusion. Singlet cells were
discerned with a stringent multiparametric gating strategy based on FSC and SSC
(pulse width and height). CD4+ T cells and BMDCs were distinguished by calcein
staining and MHCII and CD3 ﬂuorescence, and sorted on a FACSAria ﬂow cyt-
ometer (BD Biosciences). DNA was extracted, and C57BL/6 and NZB mtDNAs
were detected by restriction fragment length polymorphism (RFLP) analysis as
follows. DNA (50 ng) was PCR-ampliﬁed using the RED Extract-N-Amp PCR
Ready Mix Kit (Sigma Aldrich) with the oligonucleotides 5’ AAGCTATCGGG
CCCATACCCCG 3’ (Fw) and 5’ GTTGAGTAGAGTGAGGGATGGG 3’ (Rv) at a
concentration of 250 nM (Tm: 58°). After PCR ampliﬁcation, samples were
digested with BamH1 (10 units) for 2 h. Digested samples were loaded on a 2%
agarose gel. C57NZB haplotype includes a BamHI restriction site; enzyme digestion
results in two smaller fragments of 414 and 250 pb. Digestion of PCR products
from C57C57 haplotype results in a single band of 664 pb corresponding to the full
length PCR product.
Conjugate formation of cell lines and mitoDsRed transfer. To distinguish Raji B
cells from T cells, Raji cells were loaded with the cell tracer CMAC (7-amino-4-
chloromethylcoumarin, Invitrogen). For antigen stimulation and IS formation, Raji
cells were pulsed for 30 min with 0.5–1 μg/ml of Staphylococcus enterotoxin
superantigen (SEE, Toxin Technology) and mixed with Jurkat cells expressing
CD63-GFP, TFAM-dsRED, or mitoYFP at a ratio of 1:5 for 18–24 h at 37 °C. Cell
conjugates were analyzed by FACS in a FACS LSRFortessa Cell Analyzer (BD
Biosciences) and data were analyzed with FACSDiva software (BD Biosciences).
To assess gene expression after IS formation, stable J77 CD63-GFP cells and
CMAC-stained Raji cells were conjugated as described. After 16 h, cells were sorted
according to CMAC staining and CD63 green ﬂuorescence. The Raji population
was split into two groups according to CD63-GFP uptake: Raji GFP+ Low (cells
acquiring low amounts of CD63) and Raji GFP+High (acquiring high amounts of
CD63). After sorting, total RNA was isolated and qPCR performed to analyze
antiviral response genes.
Exosome puriﬁcation and sucrose-gradient puriﬁcation. Cells were cultured in
medium supplemented with 10% exosome-depleted fetal bovine serum (FBS,
Invitrogen; FBS was depleted of bovine exosomes by overnight centrifugation at
100,000 × g for at least 16–20 h. Exosomes were obtained by serial centrifugation as
described20. Brieﬂy, cells were pelleted (300 × g for 10 min) and the supernatant
was centrifuged at 2000 × g for 20 min to remove debris and dead cells. The col-
lected supernatant was then ultracentrifuged at 10,000 × g for 40 min at 4 °C
(Beckman Coulter Optima L-100 XP, Beckman Coulter) to remove debris, apop-
totic bodies, and shedding vesicles. Exosomes were pelleted by ultracentrifugation
at 100,000 × g for 70 min at 4 °C, washed in PBS, and collected by ultra-
centrifugation at 100,000 × g for 70 min. DNase treatment was performed with
RQ1 RNase-Free DNase (Promega) according to the manufacturer’s instructions.
Exosomes were isolated by sucrose density gradient. Brieﬂy, exosomes were
obtained by serial centrifugation of 200 ml cell culture supernatant. Isolated
exosomes were layered on top of a discontinuous sucrose gradient, ranging from
2.5 M sucrose at the bottom to 0.4 M sucrose at the top, in an SW40 centrifuge tube
(14 × 95 mm; Beckman Coulter). Tubes were centrifuged overnight (18–20 h) in a
SW40 rotor at 192,000 × g at 4 °C. One ml fractions were collected from the top of
the gradient and were resuspended in an equal volume of acetone for protein
precipitation and Western blot analysis or were treated as indicated for DNA
isolation and PCR analysis.
Exosome adsorption to aldehyde sulfate beads and detection. Exosomes were
obtained as described above, resuspended in PBS, and coupled to 4 μm aldehyde
sulfate beads (Invitrogen) 15 min in rotation at room temperature. Then, coupled
beads where incubated in overnight rotation in PBS containing 0.1% BSA and
0.01% sodium azide. Beads were washed twice with PBS, 0.1% BSA, 0,01% sodium
azide. For surface staining, beads were washed and incubated with the indicated
primary antibodies for 30–45 min on ice. For intraluminal staining, beads were
ﬁxed and permeabilized in PBS containing 1% Paraformaldehyde and 0.01% Triton
X-100 for 20 min on ice, washed, and incubated with primary antibodies for 1 h on
ice. Beads were then washed and incubated with the appropriate secondary anti-
bodies for 30 min on ice. Beads were analyzed with a FACS LSRFortessa Cell
Analyzer (BD Biosciences) and data were analyzed with FACSDiva software (BD
Biosciences). Negative controls were obtained with permeabilized and non-
permeabilized exosome-coupled beads incubated with the indicated secondary
antibodies.
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Nanoparticle tracking analysis. Exosome numbers and size distribution were
measured from the rate of Brownian motion in a NanoSight LM10 system, which is
equipped with fast video capture and particle-tracking software (NanoSight,
Amesbury, UK). Brieﬂy, 0.5 ml of diluted exosome fraction was loaded into the
sample chamber of an LM10 unit (Nanosight, Amesbury, UK) and three 30-s
videos were recorded of each sample. Data were analyzed with NTA 2.1 software
(Nanosight). Samples were analyzed using manual shutter and gain adjustments,
which resulted in shutter speeds of 15 or 30 ms, with camera gains between 280 and
560. The detection threshold was kept above 4; blur: auto; minimum expected
particle size: 50 nm. Samples were diluted before analysis to concentrations
between 2 × 108 and 20 × 108 particles/ml.
Deep-sequencing analysis. Total RNA was extracted with the RNeasy kit (Qia-
gen). Contaminating genomic DNA was removed using the speciﬁc column from
the kit. RNA integrity and quantity were determined in an Agilent 2100 Bioana-
lyzer. Equal RNA amounts from four individual samples per group were analyzed
in the Illumina Genome Analyzer IIx. Sequencing reads were pre-processed by
means of a pipeline that used FastQC to assess read quality and Cutadapt to trim
sequencing reads, eliminate Illumina adapter remains, and discard reads shorter
than 30 bp. The resulting reads were mapped against the mouse transcriptome
(GRCm38, release 76; aug2014 archive) and quantiﬁed using RSEM v1.17. Data
were then processed with a pipeline that used the EdgeR Bioconductor package for
normalization and differential expression analysis in a paired strategy.
The number of reads obtained per sample was in the range of 12 to 17 million.
The percentage of reads eliminated in the pre-processing step was below 1%. Genes
with at least 1 count per million in at least four samples (11,383 genes) were
considered for further analysis. Fold change and log(ratio) values were calculated to
represent gene expression differences between conditions. Sets of genes
differentially expressed across conditions were analyzed for functional associations
using the Ingenuity Knowledge Database (IPA, http://www.ingenuity.com).
Exosome proteomic analysis. Exosomes from mouse T lymphoblasts were iso-
lated by serial ultracentrifugation, and protein extracts (200 µg) were digested using
the FASP method as previously described68. After digestion, the resulting peptides
were desalted onto C18 OMIX tips (Agilent Technologies). Peptides were separated
into four fractions by cation exchange chromatography with MCX cartridges
(Waters) using graded concentrations of ammonium formate, pH 3.0 in acetoni-
trile (ACN), and desalted again before analysis by liquid chromatography–tandem
mass spectrometry (LC-MS/MS).
Analyses were performed using a nano-HPLC Easy nLC 1000 chromatograph
coupled to a Q-Exactive hybrid quadrupole orbitrap mass spectrometer (Thermo
Scientiﬁc). Peptides were loaded in an analytical C18 nano-column (EASY-Spray
column PepMap RSLC C18, 75 μm internal diameter, 3 μm particle size, and 50 cm
length, Thermo Scientiﬁc) and separated in a continuous gradient consisting of
8–30% B for 60 min and 30–90% B for 2 min (B= 90% ACN, 0.1% formic acid) at
200 nl/min. The chromatographic run acquired an FT-resolution spectrum of
140,000 ions in the mass range of m/z 390–1600 followed by data-dependent MS/
MS spectra of the 15 most intense parent ions. Normalized HCD collision energy
was set to 28% and the parent ion mass isolation width was 2-Da.
Peptides were identiﬁed from MS/MS spectra using the SEQUEST HT
algorithm integrated in Proteome Discoverer 2.1 (Thermo Scientiﬁc). MS/MS scans
were matched against a mouse protein database (UniProt 2016_07 Release) and the
parameters were selected as follows: a maximum of two missed trypsin cleavages, a
precursor mass tolerance of 800 ppm, and a fragment mass tolerance of 0.02 ppm.
Cysteine carbamidomethylation was chosen as the ﬁxed modiﬁcation and
methionine oxidation as the dynamic modiﬁcation. The same MS/MS spectra
collections were searched against inverted databases constructed from the same
target databases. SEQUEST results were analyzed by the probability ratio method.
False discovery rate (FDR) was calculated for peptides identiﬁed in the inverted
database search results using the reﬁned method69.
Detection of oxidized DNA by chromatin immunoprecipitation. T lymphoblast
exosomes were puriﬁed by differential ultracentrifugation and lysed in buffer
containing 25 mM Tris-HCl, 150 mM NaCl, 2 mM MgCl, 0.5%, NP40, 5 mM DTT.
Protein G-coupled magnetic beads (Protein G Dynabeads, Invitrogen) were washed
and incubated for 2–3 h with 5 µg anti-8 hydroxyguanosine (8-OHdG) antibody
[15A3] (Abcam), 5 µg of anti-DNA AC-30-10 (Progen), or with 5 µg of the isotype
control (Santa Cruz, sc-2015). Lysates were precleared with Protein G Dynabeads
and then incubated overnight at 4 °C with antibody-coupled beads. Samples were
washed ﬁve times with lysis buffer and eluted with 50 mM Tris-HCl pH 8.0, 10 mM
EDTA, and 1% SDS for 1 h at 65 °C. DNA was puriﬁed with the ChIP DNA Clean
& Concentration kit (D5205-Zymo Research). qPCR was performed on whole
samples with technical duplicates.
Mitochondrial enriched fraction was obtained from T lymphoblasts by
resuspending them in mitochondrial extraction buffer (1 mM EDTA pH 8.0, 1 mM
DTT, 10 mM NaCl, 3 mM MgCl2, 5 mM Tris-HCl pH 8.0) during 15 min at 4 °C
(Osmotic Lysis). Then, lysates were subjected to three freeze/thaw cycles with 5 min
liquid nitrogen exposition and 10 min immersion in a water bath at 37 °C.
Following lysis the tubes were centrifuged at 500× g for 10 min at 4 °C.
Supernatants were collected and spun down at 12,000 × g for 20 min at 4 °C. The
ﬁnal pellets (mitochondria enriched fraction) were resuspended in lysis buffer and
treated as exosomal fractions.
Analysis of antiviral response induction by exosomes. BMDCs were cultured
and differentiated in vitro. After culture for 9–11 days, BMDCs were plated in p12
plates at 3 × 105 per well. Exosomes from T lymphoblasts were isolated by dif-
ferential ultracentrifugation and 10–15 μg added to BMDCs for 6 h. BMDCs were
then washed and frozen for RNA extraction.
Vaccinia infection. The recombinant vaccinia virus VACV-GFP was a gift from J.
Yewdell (National Institutes of Health, Bethesda, MD). For analysis of exosome-
mediated viral protection, BMDCs were cultured as previously described. After
9–11 days, cells were plated in p96 plates at 1 × 105 per well. T lymphoblast
exosomes were puriﬁed by differential ultracentrifugation and 5–10 μg were added
to BMDCs for 4–6 h. Vaccinia-GFP was added to cells at the indicated BMDC:virus
ratios. After incubation for 4 h, cells were harvested, ﬁxed for 10 min with BD
Cytoﬁx/Cytoperm (BD Biosciences), and analyzed by ﬂow cytometry. Viability was
assessed with the LIVE/DEAD® Fixable Aqua Dead Cell Stain Kit (Molecular
Probes).
For the analysis of antiviral protection during IS formation, BMDCs were
cultured for 9–11 days and then plated in p24 plates at 2 × 105 per well. Receptor
BMDCs were primed with 100 ng/ml LPS overnight, extensively washed, and co-
cultured in the presence of ovalbumin (OVA) peptide (5 μg/ml) with C57BL/6
CD4+ OT-II T cells (5:1 T cell/DC ratio). After conjugate formation for 4 h,
vaccinia-GFP was added at a 1:1 ratio (total number of cells in the well) for 4 h.
Cells were harvested, blocked with Fc-block (CD16/CD32, BD Pharmingen), and
stained with CD4 PE-Cy7 and CD11c PE. Viability was assessed with the LIVE/
DEAD® Fixable Aqua Dead Cell Stain Kit (Molecular Probes). Cells were ﬁxed for
10 min with BD Cytoﬁx/Cytoperm (BD Biosciences) and analyzed by ﬂow
cytometry.
Cell viability assay. In order to measure cell viability upon manumycin treatment
and activation, CD4+ OT-II T lymphoblasts were incubated for 24 h with
increasing amounts of manumycin (0, 1, and 2.5 µM) and with anti-CD3
(10 µg/ml) and anti-CD28 (2 µg/ml). Cells were harvested and stained with anti-
CD4 and DAPI to measure the percentage of DAPI negative (alive) CD4+ cells by
ﬂow cytometry.
To ascertain cell viability in the context of immune cognate interactions,
CD4+OT-II T lymphoblasts were pre-treated for 2 h with increasing amounts of
manumycin (0, 1, and 2.5 µM),then CD4 T cells were conjugated with OVA-pulsed
dendritic cells (5:1 T cell/DC ratio; 4 h). Cells were harvested and stained with anti-
CD4 and DAPI to measure the percentage of DAPI negative (alive) CD4+ cells by
ﬂow cytometry.
Flow cytometry. For cytometry, adherent cells were harvested with 0.25% Trypsin-
EDTA (Gibco), blocked with Fc-block (CD16/CD32, BD Biosciences), washed in
PBS, 1% BSA, and incubated with primary antibodies diluted in PBS, 1% BSA.
Viable cells were identiﬁed by HOECHST 58 exclusion. Singlet cells were discerned
based on FSC and SSC (pulse width and height). For surface labeling, cells were
stained with antibodies diluted in PBS, 0.5% BSA on ice.
For intracellular and surface staining, cells were ﬁxed with 1% formaldehyde
and permeabilized with 0.01% Triton X-100 (Sigma). After washing, cells were
blocked with Fc-block (CD16/CD32, BD Biosciences), washed in PBS, 1% BSA, and
incubated sequentially with primary and secondary antibodies (diluted 1:500) in
PBS, 1% BSA. Cells were then analyzed by FACS in a FACS LSRFortessa Cell
Analyzer (BD Biosciences). Data were analyzed with FACSDiva software (BD
Biosciences).
To detect intracellular ROS, HEK293T cells were incubated with
2’,7’–dichloroﬂuorescin diacetate (DCDFA, Thermoﬁsher), and to detect
mitochondrial mass cells were loaded with mitotracker green (Invitrogen). Cells
were analyzed in a FACS LSRFortessa Cell Analyzer (BD Biosciences) and data
were analyzed with FACSDiva software (BD Biosciences).
Western blot. Cells or exosomes were lysed in RIPA buffer (50 mM Tris-HCl pH
8.0, 150 mM NaCl, 1% Triton X-100, 0.1% sodium deoxycholate, and 0.1% SDS)
supplemented with a protease inhibitor cocktail (Complete, Roche). Proteins were
separated on 10–12% acrylamide/bisacrylamide gels and transferred to nitro-
cellulose or methanol-pre-treated PVDF membranes. Membranes were incubated
with primary antibodies (1:1000) and peroxidase-conjugated secondary antibodies
(1:5000), and proteins were visualized with LAS-3000.
Immunoﬂuorescense. For immunoﬂuorescence assays, cells were plated onto
slides coated with ﬁbronectin (50 μg/ml), incubated overnight, and ﬁxed with 2%
paraformaldehyde in PBS. Cells were permeabilized with PBS, 0.1% Triton X-100
(Sigma), washed and stained with the corresponding primary antibodies
(1:100–1:200) followed by secondary antibodies (1:500) (Life Technologies). When
indicated, cells were previously transfected with the indicated plasmids. Cells were
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ﬁxed and stained with the indicated antibodies at 24 h post transfection. Samples
were examined with a Leica SP5 confocal microscope ﬁtted with a ×63 objective,
and images were processed and assembled using Leica software. Quantiﬁcation of
images was done with Fiji software (ImageJ) using Manders’ coefﬁcient M2 as a
marker for co-localization of mitochondrial markers (SSBP1) with endosomal
markers (EEA1 and CD63)70. More than one hundred cells were quantiﬁed for
experiment.
TIRFm analysis of isolated exosomal particles. Isolated exosomal particles
(8 × 106 particles per coverslip) generated as described and quantiﬁed with
Nanosight were spun in a sucrose cushion (10% in HBSS; 10,000 × g, 15 min, 25 °C.
HS-4 rotor, Sorvall) over 13 mm diameter precision coverslips (thickness No. 1.5
H; 0.170 mm ± 0.005 mm, 0117530 Marienﬁeld) coated with 250 µg/ml Poly-L-Lys
(P6407 Sigma Aldrich) and ﬁxed in 1% paraformaldehyde (HBSS, 5% sucrose;
RT15710 Electron Microscopy Sciences) for 5 min, R/T. Coverslips were treated
with Glycine 200 mM in Tris-HCL (pH 7.4) for 10 min, R/T and blocked (3% BSA,
20 µg/ml human gamma-globulins in HBSS) for 1 h R/T. Staining with anti-CD81
(rat anti-mouse clone MT81; 5 µg/ml, 4 °C, o/n) was followed by highly cross-
adsorbed Alexa-568-conjugated goat anti-rat Antibody (A-11077 Thermoﬁsher
Scientiﬁc 1:1000). Samples were then permeabilized with a 0.2% TX-100 solution
(HBSS supplemented with 0.5% paraformaldehyde and 1.5% BSA), treated for
autoﬂuorescence and stained with anti-DNA (0.001 µg/ml) or anti-TSG101 (20 µg/
ml, ab83 Abcam) mouse monoclonal antibodies for 3 h at 4 °C, followed by highly
Cross-absorbed Alexa-488-conjugated goat anti-mouse Antibody (A-11029 Ther-
moﬁsher Scientiﬁc 1:1000). Samples were mounted on Prolong Gold antifade
mountant (P36930 Thermoﬁsher Scientiﬁc). Coverslips were extensively washed
with HBSS and a ﬁnal wash with deionized water. Antibodies were diluted in 1.5%
BSA in HBSS. Secondary antibodies were incubated for 1 h at R/T. All the solutions
used for coverslip preparation and immunoﬂuorescence were previously ultra-
centrifuged at 100,000 × g for 70 min (4 °C) in a swinging bucket rotor (Beckman
Coulter) or for 30 min at 13,200 × g in a ﬁxed-angle rotor (Eppendorf). Samples
were imaged under a Leica AM TIRF MC M system mounted on a Leica DMI
6000B microscope ﬁtted with a HCX PL APO 100 × 1.46 NA oil objective and
coupled to an Andor-DU8285 VP-4094 camera. Penetration depth was 90 nm and
×2 zoom was used to obtain an optical magniﬁcation of the samples. Equal
experimental conditions for acquisition were used for the different coverslips.
Brightness and Contrast adjustments were equal for all images. Processing of
images was performed with Image J 1.51n (Wayne Rasband national Institutes of
Health, USA. http://imagej.nih.gov/ij; Java 1.8.0_66; 64 bit).
Electron microscopy. Adherent HEK293 cells stably transfected with control
shRNA, shRab27a, or shnMNase2 were washed in PBS and ﬁxed for 1 h in 2.5%
glutaraldehyde in 0.1 M phosphate buffer at room temperature. Cells were pelleted
in 15 ml Falcon tubes. Pellets were washed with phosphate buffer and incubated
with 1% OsO4 for 90 min at 4 °C. Samples were then dehydrated, embedded in
Spurr, and sectioned on a Leica ultramicrotome (Leica Microsystems). Ultrathin
sections (50–70 nm) were stained with 2% uranyl acetate for 10 min and with a
lead-staining solution for 5 min and observed under a JEOL JEM-1010 transmis-
sion electron microscope ﬁtted with a Gatan Orius SC1000 (model 832) digital
camera.
For immunogold staining, cells were ﬁxed in 4% PFA 0.5% glutaraldehyde in
PBS at 4 °C. Samples were dehydrated, embedded, and sectioned. Grids were
rehydrated in TBS and treated with 0.01 M glycine to deactivate reactive aldehydes.
Samples were blocked with goat blocking solution (Aurion) for 1 h and incubated
with primary antibodies; anti-Tfam (1:50) (Cell Signalling) and anti-DNA (1:15)
(Promega) overnight in blocking solution. Grids were washed in blocking solution
and incubated with secondary antibodies conjugated to 12 nm colloidal gold (1:75
for TFAM and 1:25 for DNA, Jackson ImmunoResearch) for 2 h. Samples were
washed in blocking solution and distilled water. Grids were air dried for 2 h, stained
with lead citrate and uranyl acetated and carbon coated for viewing under
transmission electron microscope.
Extracellular ﬂux analysis. Oxygen consumption rate was measured in a XF-96
Extracellular Flux Analyzer (Seahorse Bioscience) in equal numbers of shControl,
shRab27a and shnSMase2 HEK293 cells incubated with XF medium. Three mea-
surements were obtained under basal conditions and upon addition of oligomycin
(1 mM), ﬂuoro-carbonyl cyanide phenylhydrazone (FCCP; 1.5 mM), and rotenone
(100 nM)+ antimycin A (1 mM).
Quantitative PCR and assessment of mitochondrial DNA by PCR. Total RNA
was isolated using the RNeasy kit (Qiagen). Genomic DNA was removed using the
speciﬁc column from the kit. Reverse transcription was performed using the High
Capacity cDNA Reverse Transcriptase kit (Applied Biosystems). Quantitative real-
time PCR was performed in a 7900 HT Fast Real-Time PCR system (Life tech-
nologies) using SYBR green qPCR Master Mix (Promega). Data were normalized to
the expression of beta-actin, beta-2-microglobulin, and/or ywhaz and analyzed
with Biogazelle QBasePlus (Biogazelle). Primer sequences are speciﬁed in Supple-
mentary Table 1.
For the analysis of mitochondrial DNA contained in exosomes, DNA from T
lymphoblast-derived exosomes was isolated with the Cell Lysis Solution and
Protein Precipitation Solution from Qiagen. After DNA isolation, PCR was
performed, primer sequences are speciﬁed in Supplementary Table 2.
Statistical analysis. All values were expressed as the mean ± S.E.M. or mean with
individual values included for data distribution. For in vitro experiments, statistical
differences were evaluated with Student’s t-test and between group differences were
evaluated with the Mann–Whitney U test for unpaired data (GraphPad Prism).
Differences were considered signiﬁcant when *p < 0.05, **p < 0.01, ***p < 0.001.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles, or are
available in a persistent repository or upon reasonable requests to the authors.
Deep-sequencing analysis data supporting the ﬁndings of this study are
deposited in GEO repository with the accession number: GSE110165
DNAseq data are deposited in BioSample repository: SRP148571
Raw data from RNAseq and DNAseq analysis are under a common umbrella
project: Bioproject PRJNA472779:
PRJNA432987: Mouse RNAseq data in GEO
PRJNA472354: Human DNASeq data in SRA
The mass spectrometry proteomics data are deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the data set identiﬁer
PXD008843.
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